William Roth

About William Roth

Bill is the SVP of IntegriChain’s Consulting and Advisory Businesses including the well-known Blue Fin Group which he founded in 2001. Bill is an expert in commercialization for every form of pharmaceuticals working to develop holistic strategies to ensure that innovative science comes to market and patients have affordable access. The consulting businesses that Bill runs support over 450 manufacturers including all of the top 40 and spans all forms of products including Specialty, Orphan Rare, Cell and Gene, Vaccines, Biosimilars, and of course Primary Care Brand and Generic products. Throughout his 30+ year he has been a serial entrepreneur and accomplished corporate employee functioning as a thought leader developing and executing new business models for startups and Fortune 100s in the pharmaceutical and healthcare industry. Bill is an accomplished consultant disciplined in strategy, business development, commercial operations, marketing, channel and patient services design, and the design and use of technology. He has been publicized in dozens of industry publications over his career for thought leadership and frequently cited by market researchers and analysts for his accurate predictions of future events. He has been a frequent speaker at industry events and seminars. He was featured in the cover story of Entrepreneur Magazine in 2001, was a 2008 recipient of PharmaVOICE magazine’s “Top 100 most-inspiring people in Life Sciences” and a 2009 PM360’s “People to Watch”. In 2016, Bill was featured as the cover story in Pharmaceutical Commerce for his predictions of what the Life Sciences industry would look like out to 2030, which have proven to be highly accurate to date. Specialties: Healthcare, Pharmaceuticals, Biologics, Generics, Medical Device, Consumer Health, Consulting, Commercialization, Channel Strategy, Data & Data Analytics, Technology, Pricing and Contracting, Sales and Marketing, Brand Management, Product Management, Patient Access, Patient Services, Payer Strategy, Pharmacy and Distribution Strategy, Product Launch and End-Of-Lifecycle management

Experience

1. SVP Consulting and Advisory Services

   IntegriChain

   Jan 2022 — Present · US

   As SVP Consulting and Advisory Services, I have responsibility for Integrichain\'s Management Consulting (Blue Fin Group) and Advisory Services. Our team of approximately 75 people consult and advise 450 clients including all 40 of the top 40 pharmaceutical companies. We span 9 areas of focus including regulatory and policy, finance and GTN, Reimbursment and Pricing including Government Pricing, Product Strategy including New Product Planning, Payer Access and Strategy, Provider and Pharmacy Strategy, Patient Access and Affordability, Distribution & Logistics, and Data & Technology. Our team hails from large consultancies and the Life Sciences industry. When you work with us, expect the highest level of professional Consulting and Advisory with unmatched depth of subject matter expertise.

Education

• Saint Michael's College

  Business, Healthcare, Marketing, Investments

  1986 — 1990

Skills

• Biosimilars
• Supply Chain
• Managed Care
• Management Consulting
• Market Research
• Lifesciences
• Commercialization
• Crm
• Pharmaceuticals
• Competitive Analysis
• Start-Ups
• Leadership
• Oncology
• Pricing
• Generic Pharmaceuticals
• Pharmaceutical Sales
• Channel Strategy
• Healthcare
• Business Development
• Pharmaceutical Industry
• Business Planning
• Biotechnology
• Product Launch
• Commercialization Strategies
• Strategy
• Generic Drugs
• Medical Devices
• Enterprise Software
• Cross-Functional Team Leadership
• Consumer Healthcare
• Marketing
• Hospital Sales
• Product Launches
• Life Sciences
• Product Management
• Sales Effectiveness
• Management
• Entrepreneurship